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Abstract 
Understanding intestinal absorption for pharmaceutical compounds is vital to estimate 
bioavailability and therefore the in vivo potential of a drug. This study considers the 
application of micellar liquid chromatography (MLC) to predict passive intestinal absorption 
with a selection of model compounds. MLC is already known to aid prediction of absorption 
using simple surfactant systems however, with this study the focus was on the presence of a 
more complex, bile salt surfactant, as would be encountered in the in vivo environment. As a 
result, MLC using a specific bile salt has been confirmed as an ideal in vitro system to predict 
the intestinal permeability for a wide range of drugs, through the development of a 
quantitative partition-absorption relationship. MLC offers many benefits including 
environmental, economic, time-saving and ethical advantages compared with the traditional 
techniques employed to obtain passive intestinal absorption values.  
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Introduction 
The most favourable option for drug administration is the oral route, accounting for 
the majority of pharmaceutical formulations on the market. A large percentage of these 
products are absorbed within the gastrointestinal (GI) tract thus it is essential to quantify the 
extent of absorption to predict bioavailability. Most new chemical entities (NCEs) intended 
for oral administration are within Class II or IV of the Biopharmaceutics Classification 
System (BCS), i.e. of low aqueous solubility (Williams, Trevaskis, Charman, Shanker, 
Charman, Pouton and Porter 2013). As a result these compounds tend to exhibit poor 
bioavailability which can be problematic for development. Facilitating the prediction of drug 
absorption is therefore fundamental to maximise potential bioavailability, and consequently, 
efficacy of an NCE. 
 Traditionally, in vivo performance following oral administration has been predicted 
using animal models. In recent years this has been less favourable for reasons including 
interspecies variability (Martignoni, Groothuis and de Kanter 2006), substantial economic 
costs and ethical considerations (Zurlo and Hutchinson 2014). For these reasons research has 
focused on the development of alternatives to such models. One of the most widely 
researched in vitro methods to simulate in vivo performance is the application of dissolution 
studies in biorelevant media (Berthelsen, Sjögren, Jacobsen, Kristensen, Holm, Abrahamsson 
and Müllertz 2014). It is believed that the use of physiologically relevant media is crucial as 
the components present, for example bile salts, are present in intestinal fluids allowing a 
closer replication of the in vivo scenario (Tomaszewska, Karki, Shur, Price and Fotaki 2013). 
The composition of GI fluids is well characterised with respect to pH, buffer capacity, 
osmolarity, surface tension and lipid concentration under fasted and fed conditions. 
Numerous studies have confirmed the relationship between the impact of these properties 
through preformulation studies, allowing an estimation of the fraction of drug absorbed in 
vivo for orally administered compounds (Bergström, Holm, Jørgensen, Andersson, Artursson, 
Beato, Borde, Box, Brewster, Dressman, Feng, Halbert, Kostewicz, McAllister, Muenster, 
Thinnes, Taylor and Mullertz 2014). However, some researchers have found that dissolution 
testing by itself may not be adequate and it may be more beneficial to undertake the 
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simultaneous assessment of dissolution and permeation (Sugano, Kataoka, da Costa Mathews 
and Yamashita 2010). 
 Another technique to predict in vivo permeability is the parallel artificial membrane 
permeability assay, also known as PAMPA. This assay has been used previously to predict 
permeability through a range of biological environments including skin (Ottaviani, Martel 
and Carrupt 2006), the blood brain barrier (Di, Kerns, Fan, McConnell and Carter 2003) and 
the GI tract (Bujard, Sol, Carrupt and Martel 2014). Although it has been shown to be useful 
for in vivo prediction, PAMPA does have some limitations, for example unpredictable drug 
retention for highly lipophilic drugs (Bendels, Tsinman, Wagner, Lipp, Parrilla, Kansy and 
Avdeef 2006) and a significant unstirred water layer (Avdeef, Nielsen and Tsinman 2004, 
Ruell, Tsinman and Avdeef 2003). Some of these challenges have been investigated in an 
attempt to overcome these difficulties to improve accuracy and precision with a degree of 
success in certain aspects (Buckley, Fischer, Fricker and Brandl 2012).  
 Many researchers consider the ‘gold standard’ for predicting intestinal absorption to 
be the Caco-2 model (Wuyts, Riethorst, Brouwers, Tack, Annaert and Augustijns 2015). This 
is a cell culture model consisting of monolayers cultivated on permeable growth inserts. Such 
models exhibit structural and biological properties similar to those in vivo with the expression 
of appropriate enzymes, conferring their suitability as a model system. However, cellular 
models are renowned for their limited reproducibility, extensive culturing requirements and 
economic cost (Buckley, Fischer, Fricker and Brandl 2012). Some research has attempted to 
enhance the biorelevance of permeability data, for example by using fasted state human 
intestinal fluid as the solvent system with prediction for a series of 16 model drugs (Wuyts, 
Riethorst, Brouwers, Tack, Annaert and Augustijns 2015).  
 Other less well known models have also been proposed, some of which are 
modifications of those previously discussed and others more novel. One such example of the 
latter is the application of spectrofluorimetry and derivative spectrophotometry to determine 
partition coefficients to assess the role of mixed (bile salt) micelles in gastrointestinal 
absorption (De Castro, Gameiro, Guimarães, Lima and Reis 2001). Interestingly, it was found 
that hydrophobic compounds are fully incorporated within mixed bile salt micelles whereas 
amphiphilic drugs are not.  This work demonstrates the significant effect the presence of bile 
salt micelles can have on absorption, and therefore, bioavailability.  
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One particular technique that explores the effects of micelles on the behaviour of 
compounds is micellar liquid chromatography (MLC). Approximately thirty years since its 
development, MLC has become renowned for providing a variety of analytical information 
on a wide range of chemical samples. There are several advantages for the use of MLC 
including the avoidance of organic solvents, analytical rapidity, data reproducibility, sample 
flexibility and economic savings (El-Shaheny, El-Maghrabey and Belal 2015).  MLC 
employs a mobile phase containing one, or more, surfactants over a range of concentrations. 
Ideally, the chosen surfactant will have a comparatively low critical micellar concentration 
(CMC) and aggregation number. Upon injection of the sample (solute), several competing 
phenomena occur. Each compound within the sample will partition between the bulk aqueous 
phase and micellar aggregates plus the bulk aqueous phase and surfactant-coated stationary 
phase. These interactions will dictate the retention time of the solute which can then be 
measured using a variety of analytical techniques, such as UV or fluorescence spectroscopy. 
Using well established equations  it is possible to calculate a range of physicochemical 
partitioning properties for the solute under investigation (Waters and Kasprzyk-Hordern 
2010, Waters, Shahzad and Mitchell 2012). A summary of the wide array of developments in 
MLC over recent years can be found in the work of (Ruiz-Ángel, Garcia-Álvarez-Coque and 
Berthod 2009). For example, MLC has very recently been applied in the determination of the 
lipophilicity of organic compounds alongside another technique, namely microemulsion 
liquid chromatography, as potential high-throughput screening platforms (Xu, Li, Huang, Yu, 
Wang and Li 2015). More specific applications for MLC have also been investigated, for 
example to determine blood-brain barrier penetration (Lu, Sun, Wang, Li, Liu, Fang and He 
2009, Stepnik and Malinowska 2013). In one particular study drug penetration was predicted 
and comparisons made between MLC and immobilised artificial membrane liquid 
chromatography (De Vrieze, Lynen, Chen, Szucs and Sandra 2013). This study also confirms 
the benefits of using sodium deoxycholate, including their micellisation ability and UV 
transparency although other benefits are also known, such as their low economic cost. 
Research has also focussed on prediction of ocular tissue permeability (Martín-Biosca, 
Molero-Monfort, Sagrado, Villanueva-Camañas and Medina-Hernández 2003) and modelling 
skin permeability (Martínez-Pla, Martín-Biosca, Sagrado, Villanueva-Camañas and Medina-
Hernández 2003, Waters, Shahzad and Stephenson 2013). With respect to predicting human 
drug absorption using MLC, research is incredibly limited to a small number of papers, 
employing standard surfactants as the basis of the mobile phase. For example, in 2001 
Molero-Monfort et al. published a paper using Brij 35 to develop a model based on the 
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retention of selected compounds which showed a predictive ability for drugs absorbed by 
passive diffusion (Molero-Monfort, Escuder-Gilabert, Villanueva-Camañas, Sagrado and 
Medina-Hernández 2001). This work was then followed by research published in 2014 that 
considered two further surfactants within the mobile phase, namely sodium dodecyl sulfate 
(SDS) and cetyltrimethylammonium bromide (CTAB) (Stȩpnik, Malinowska and Rój 2014).   
However, the application of MLC with micellar systems that are actually encountered 
within the GI tract, i.e. bile salt micelles, has not been investigated prior to this study. 
Through combining the advantages of MLC with the incorporation of micelles that are 
known to exist in vivo will aid the development of an in vitro model that is simple, 
reproducible, inexpensive, accurate and moreover, precise, for the prediction of human 
absorption data. 
In summary, the main aim of this study was to investigate the use of MLC with bile 
salt to develop a quantitative partition-absorption relationship, thus creating an alternative in 
vitro system to predict intestinal permeability for pharmaceutical compounds. 
 
Micellar Liquid Chromatography Method and Instrumentation 
 A detailed description of the basic MLC methodology employed in this study has 
been published previously (Waters, Shahzad and Stephenson 2013). In summary, each mobile 
phase containing the bile salt surfactant was pumped through the chromatographic system 
(Severn Analytical SA 6410B) with a reversed phase cyanopropyl column (Spherisorb 5μm, 
15cm x 4.6 mm i.d.) and a flow rate of 1.34 mL per minute. The selection of this column and 
flow rate was decided based on previous work that proves the superiority of using a 
cyanopropyl column over C18 due to its tendency to adsorb less surfactant and the binding of 
the surfactant to the bonded phase through electrostatic interaction decreasing the charged 
layer on the surface of the column (Waters, Shahzad and Stephenson 2013). Drug samples 
(0.2 mM) in a solvent identical to that of the mobile phase were injected via a Rheodyne 
injector. A UV detector (Waters 2487), set at a wavelength appropriate for each drug (221 – 
360 nm), identified retention of the solute within the column as a function of time. Data were 
recorded and then analysed to obtain retention factors and each run was repeated a minimum 
of three times to ensure reasonable accuracy and precision were achieved. A high level of 
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reproducibility was attained for the retention data with a maximum standard deviation of 
0.975 for all assays.  
 
Materials and Reagents 
An aqueous solution containing a bile salt surfactant, namely sodium deoxycholate 
(NaDC, Figure 1) (log Po/w: 1.24, CMC: 4.3-5.5 mM at 291-298 K, pKa: 6.2, Aggregation 
number: 5.1-7.1) (Olesen, Westh and Holm 2015) and (Vadnere and Lindenbaum 1982), was 
considered as a mobile phase for this study, used as purchased from Sigma Aldrich, Dorset, 
UK (97 %). NaDC was diluted with distilled water as necessary to achieve concentrations 
from 5 to 20 mM. The 16 compounds considered in this work were:  acetaminophen (99 %, 
Sigma Aldrich, Dorset, UK), fluconazole (98 %, Sigma Aldrich, Dorset, UK), indomethacin 
(99 %, Sigma Aldrich, Dorset, UK), ketoprofen (98 %, Sigma Aldrich, Dorset, UK), 
lidocaine (98 %, Sigma Aldrich, Dorset, UK), nicotinic acid (99.5 %, Sigma Aldrich, Dorset, 
UK), phenylbutazone (98.5 %, Sigma Aldrich, Dorset, UK), piroxicam (98 %, Sigma 
Aldrich, Dorset, UK), propranolol (99 %, Sigma Aldrich, Dorset, UK), acetyl salicylic acid 
(99 %, Acros organics, Geel, Belgium), diclofenac (98 %, TCI, Europe), diphenhydramine 
(98 %, TCI, Europe), theophylline (98 %, TCI, Oxford, UK), fenoprofen (97 %, Fluka, 
Dorset, UK), gemfibrozil (98 %, TCI, Europe), ibuprofen (98 %, BASF, Cheshire, UK), used 
as purchased with each at a concentration of 0.2 mM. All experimental work was conducted 
with no organic modifier or buffer present due to the formation of polymer like aggregates or 
gels upon adjusting the medium to any pH lower than 8. Retention data are averages of 
triplicates. 
 
Data Analysis  
In agreement with previous work, it was possible to calculate a value for the micelle/water 
partition coefficient (logPmw) by plotting the surfactant concentration (after subtraction of the 
CMC, i.e. 5 mM) with the inverse of the capacity factor. A representative chromatogram can 
be seen in Figure 2. It should be noted that pH and ionic strength were not maintained at a 
constant value during this work as it was thought the addition of further compounds to the 
mobile phase may interfere with the partitioning process. 
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Results from the MLC technique permitted the development of a dataset for the bile 
salt solutions that contained logPmw values for 14 different compounds along with their 
physicochemical parameters, such as molecular weight (MW) and published human intestinal 
absorption values (HIA %).  Multiple linear regression (MLR) analysis focussed on the 
development of quantitative partition-absorption relationships to correlate the MLC data for 
each drug with published in vivo data using Minitab 17
®
, Minitab Inc., State College, 
Pennsylvania (licensed to the University of Huddersfield). Once established, the equation 
relating logPmw with intestinal absorption was used to investigate two final compounds 
(indomethacin and piroxicam) to determine the applicability of the equation. 
 
Results and discussion 
Determination of log Pmw 
Sodium deoxycholate (NaDC) is a well-known bile salt surfactant present in intestinal 
fluids in the GI tract. Moreover, NaDC forms micellar structures that aid the passive 
absorption of compounds in vivo ( olm, Mul lert  and Mu 2013). The ability of NaDC-based 
MLC to predict human oral drug absorption was evaluated using a set of 14 drugs of variable 
structure and physicochemical properties. All of the compounds analysed were known to 
undergo passive absorption with reliable in vivo data available. Retention data for each 
compound led to the calculation of micelle-water partition coefficient (Pmw) values which 
were then analysed alongside oral absorption data from published literature data. A summary 
of the calculated Pmw values and percentages of oral absorption (from previously published 
data) can be found in Table 1. Also the determination coefficients (R
2
) for the linear 
equations relating the inverse of the capacity factor for all drugs against the micellar 
concentrations of NaDC used are stated in Table 2. 
Prediction of HIA values 
Although there was a linear relationship between the literature % absorption values 
and experimental logPmw values, it was decided to instead use logit(Abs) to improve this 
relation as is often used in published studies of a similar nature (Norinder, Österberg and 
Artursson 1999, Raevsky, Fetisov, Trepalina, McFarland and Schaper 2000, Zhao, Abraham, 
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Le, Hersey, Luscombe, Beck, Sherborne and Cooper 2002), summarised in Equation 1 where 
FA = fraction absorbed. 
Logit(Abs) = log(FA/(1-FA))  (1) 
As a result, all drugs with percentages of absorption of 100 % or 0 % were excluded 
from the training set for simplification. 
A series of molecular descriptors (polar surface area, freely rotating bonds, number of 
hydrogen bond donors/acceptors, molecular weight, molar volume and solubility) permitted 
the development of an appropriate equation using multiple regression analysis. Descriptors 
present in the final model were assessed for significance and relative importance using 
standardised coefficients and associated P-values where the standardised coefficients for log 
Pmw (micelle/water partition coefficient), Mwt (molecular weight) and Sw (solubility in 
water) were found to be -0.431, 1.050 and 0.761 respectively while their P values at 95 % 
confidence level were found to be 0.007, 0.000 and 0.001 respectively which proves their 
statistical significance. Through combining the data in Table 1 and Table 2 a residual plot for 
optimal regression and partial regression plots of experimental logit(Abs) values against 
logPmw, Mwt and Sw (Figures 3 and 4) facilitated the development of an equation to utilise 
experimental MLC data to predict the percentage of human intestinal absorption in vivo. 
Overall, the optimal model obtained incorporated 3 descriptors and is as follows 
(Equation 2): 
logit(Abs) = -0.410 - 0.482 logPmw + 0.00852 Mwt + 0.04799 Sw  (2) 
Where logPmw is the partition coefficient experimentally determined by MLC, Mwt is 
the molecular weight and Sw is the solubility in water (Table 2). The value obtained using 
Equation 2 can then be converted into a percentage of absorption using Equation 1. Standard 
error (S.E.) = 0.195, R
2
 = 0.86, R
2
adj.= 0.82 , R
2
Pred.= 0.75, F=20.994, PRESS=0.7, Mallows' 
Cp=4 where R
2
Pred. is the predicted coefficient of determination that determines the predictive 
power of the model, PRESS is the predicted residual sum of squares to determine the 
predictive ability of the model when compared with other models of an identical dataset and 
Mallows' Cp is  used in choosing between multiple regression models. The P-values obtained 
for this model indicate that the relationship between % HIA and Pmw values was statistically 
significant at the 95 % confidence level where they were < 0.05. The unadjusted R
2
 of 0.86 
derived from the current data indicates that the fit of the sampled drugs to the model is good, 
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with about 86 % of the variance in the outcome measure being accounted for by logPmw and 
other included descriptor values. The R
2
 Pred. value of 0.75 indicates that the fit of the drugs to 
the model is suitable and confirms the potential suitability of MLC using NaDC to predict 
oral drug absorption in the human GI tract. Furthermore, if the experimental logPmw values 
were replaced with published octanol-water values then it was found there was no 
predictability of HIA % possible, i.e. logPmw was a significant contributor to the predictive 
ability. Mallows' Cp value of (4.0) is the same as the number of predictors plus the constant 
(4.0), indicating that the model is relatively precise and unbiased in estimating the true 
regression coefficients and predicting future response. A 95 % confidence interval for the Pmw 
parameter is given by (-0.796, -0.167); a 95 % confidence interval for the Mwt parameter is 
given by (0.006, 0.011) and a 95 % confidence interval for the Sw parameter is given by 
(0.026, 0.070). A residual analysis did not detect any marked relationship between residuals 
and predicted values as illustrated. 
All covariates were statistically significant (t1=-3.42, p<0.05 for log Pmw; t1=-6.93, p<0.05 for 
molecular weight; t1=4.84, p<0.05 for aqueous solubility), with the model F-ratio also being 
statistically significant (F=20.99, p<0.05). None of the drugs used in the current dataset used 
in development of the previous model were found to have high residuals or to be influential 
according to studentised residuals or Cook’s distance. Also the consistency of the R2adj and 
R
2
Pred. does not suggest any evidence of model or data inadequacies in the current model. 
 In summary, the values presented in Table 1 for HIA % predicted versus those from 
literature show a remarkably similar trend. For example, differences between the two values 
are 0 % (theophylline) through to a maximum of only 7.6 % (acetylsalicylic acid) with the 
vast majority successfully predicting within 4 % of the literature value. 
 As a final aspect of investigation to assess the success of the model an additional two 
compounds were investigated, namely indomethacin and piroxicam. For indomethacin, with 
an experimental MLC logPmw measurement of 1.74 and applying Equation 2, the percentage 
of human intestinal absorption was calculated (i.e. predicted) to be 98.4 %. With a literature 
percentage of human intestinal absorption value of 100 % (Castillo-Garit, Cañizares-
Carmenate, Marrero-Ponce, Torrens and Abad 2014) then the model was deemed to be a 
successful method for prediction of in vivo behaviour, i.e. with less than 2 % difference 
between the calculated and literature values. A similar result was obtained for piroxicam with 
an experimental MLC logPmw measurement of 3.37 whereby the literature percentage of 
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human intestinal absorption value is known to be 100 % (Castillo-Garit, Cañizares-
Carmenate, Marrero-Ponce, Torrens and Abad 2014) and the predicted value was 98.7 %. 
Comparison with other methods to predict HIA 
Predicting the extent to which drugs may permeate the intestinal barrier is a key factor 
in predicting subsequent bioavailability. As previously discussed, there are several methods 
to predict intestinal absorption with data publicly available which allows comparisons to be 
made between this MLC-based method and others. Firstly, compared with Caco-2 absorption 
data, it can be said that the MLC method is comparable in predictive ability yet simpler, 
faster and cheaper to undertake. A variety of values have been published for Caco-2 
absorption, such as the work of Stepnik et al. (Stȩpnik, Malinowska and Rój 2014), with 
published data ranging in predictive ability where, in general, the level of prediction is similar 
to that published in this work. Based on the comparable ability of MLC for prediction along 
with the variety of advantages it appears to confirm its potential as a method of choice.  
 Secondly, artificial membrane based techniques, such as PAMPA, have been applied 
to the prediction of intestinal absorption. As with published data for Caco-2 absorption 
models, predictions have been made using PAMPA and their success rate have been 
generally high, for example the work of (Bujard, Sol, Carrupt and Martel 2014). Again, the 
predictive ability of the MLC method presented in this paper is generally comparable with 
that using artificial membranes yet does not pose the same limitations as discussed earlier.  
 Thirdly, MLC has been considered prior to this work in a limited manner with the use 
of simpler surfactant systems, such as SDS and Brij 35. In this case there are no advantages 
related to the method employed as both require a similar set-up and therefore time and 
economic requirements. However, the benefits of using a bile salt surfactant are clearly 
evident based on the increased similarity to the in vivo scenario which is reflected in the 
enhanced predictive ability. For example, compared with the work of Molero-Monfort et al. 
(Molero-Monfort, Escuder-Gilabert, Villanueva-Camañas, Sagrado and Medina-Hernández 
2001) and Stepnik et al. (Stȩpnik, Malinowska and Rój 2014), the data presented in this 
research displays a closer fit with human intestinal absorption data. Also other work has been 
undertaken using sodium cholate and sodium taurodeoxycholate which were also used in 
prediction of intestinal absorption and the obtained models support the closer fit of the data in 
this paper to human intestinal absorption. These comparisons highlight the importance of 
surfactant choice when designing MLC experiments as it is very clear that the composition of 
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the mobile phase can significantly affect drug retention which will ultimately affect 
absorption prediction.  
 
Conclusions 
 Determining a good prediction of intestinal absorption chromatographically is an 
exciting advance in analysis for many reasons, not only for the replacement of using animal 
models but also to save time and money which will consequently help enhance the 
development of new drugs. Based on analysis for these model compounds it has been found 
that NaDC is suited to intestinal absorption prediction and appears to provide superior 
prediction compared with alternative methods. Furthermore, data presented in this study 
could be expanded to display the more general predictive ability of MLC for a wider set of 
compounds thus confirming its potential as a general method for predicting human intestinal 
absorption. 
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Figure 1. Structure of sodium deoxycholate. 
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Figure 2. A representative chromatogram to permit calculation of logPmw, in this particular 
case for caffeine over a series of sodium deoxycholate concentrations, highlighting the shift 
in retention time with bile salt concentration. 
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Figure 3. Residual plot for optimal regression model. 
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Figure 4. Partial regression plots of experimental logit(Abs) values against log Pmw, Mwt and 
Sw 
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Table 1. Experimentally determined Pmw values (Pmw (Expt)), published literature absorption 
values (HIA % (Lit)), calculated and predicted human oral absorption data (% HIA Pred.)  
Drug 
Pmw  
(Expt) 
HIA 
% 
(Lit) 
HIA  % 
Pred. 
(Reference) 
Acetaminophen 
1.26±0.149 
R2=0.98 80 74.7 
(Castillo-Garit, 
Cañizares-Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Acetylsalicylic 
acid 
1.52±0.293 
R2=0.99 82 74.4 
(Castillo-Garit, 
Cañizares-Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Diclofenac 
1.56±0.027 
R2=0.97 97 95.9 
(Hou, Wang, Zhang 
and Xu 2007) 
Diphenhydramine 2.47±0.415 72 79.2 
(Paixão, Gouveia 
and Morais 2012) 
Fenoprofen 
1.22±0.696 
R2=0.93 85 92.2 
(Hou, Wang, Zhang 
and Xu 2007) 
Fluconazole 
1.44±0.071 
R2=1 97.5 97.4 
(Castillo-Garit, 
Cañizares-Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Gemfibrozil 
1.48±0.035 
R2=0.96 95 91.1 
(Paixão, Gouveia 
and Morais 2012) 
Ibuprofen 1.46±0.032 80 81.7 
(Balon, Riebesehl and 
Müller 1999) 
Indomethacin 
1.74±0.019 
R2=0.96 100 98.4 
(Castillo-Garit, 
Cañizares-
Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Ketoprofen  
0.91±0.01 
R2=0.94 92 95.4 
(Castillo-Garit, 
Cañizares-Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Lidocaine 
2.18±0.163 
R2=0.97 75 78.6 
(Varma, Sateesh and 
Panchagnula 2005) 
(Molero-Monfort, 
Escuder-Gilabert, 
Villanueva-Camañas, 
Sagrado and Medina-
Hernández 2001),  
Nicotinic acid 
1.22±0.069 
R2=0.97 88 89.2 
(Castillo-Garit, 
Cañizares-Carmenate, 
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Marrero-Ponce, 
Torrens and Abad 
2014) 
Phenylbutazone 
1.42±0.003 
R2=0.91 98 97.2 
(Hou, Wang, Zhang 
and Xu 2007) 
Piroxicam 
3.37±0.604 
R2=0.97 100 98.7 
(Castillo-Garit, 
Cañizares-
Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Propranolol 
1.81±0.189 
R2=0.98 90 89.5 
(Castillo-Garit, 
Cañizares-Carmenate, 
Marrero-Ponce, 
Torrens and Abad 
2014) 
Theophylline 
1.12±0.266 
R2=0.92 98 98.0 
(Kansy, Senner and 
Gubernator 1998) 
 
 
Table 2 Relevant physicochemical parameters of the selected drugs analysed for 
development of the quantitative partition-absorption relationship. 
Drug Mwt
a
 Sw
b
 HBD
a 
HBA
a 
RB
a 
TPSA
a 
VM
c 
Acetaminophen 151.20 4.15 2 2 1 49.3 131.1 
Acetylsalicylic acid 180.16 1.46 1 4 3 63.6 139.6 
Diclofenac 296.15 0.00447 2 3 4 49.3 206.8 
Diphenhydramine 255.35 0.0752 0 2 6 12.5 249.2 
Fenoprofen 242.27 0.0811 1 3 4 46.5 204.7 
Fluconazole 306.27 1.39 1 7 5 81.6 205.3 
Gemfibrozil 250.33 0.0278 1 3 6 46.5 239.7 
Ibuprofen 206.28 0.0684 1 2 4 37.3 200.3 
Indomethacin 357.79 0.0024 1 4 4 68.5 269.6 
Ketoprofen  254.28 0.0213 1 3 4 54.4 212.2 
Lidocaine 234.34 0.593 1 2 5 32.3 238.8 
Nicotinic acid 123.11 18.00 1 3 0 50.2 95.2 
Phenylbutazone 308.37 0.144 0 2 5 40.6 262.8 
Piroxicam 331.35 23.00 2 6 2 108.0 222.8 
Propranolol 259.34 0.0794 2 3 6 41.5 237.2 
Theophylline 180.16 22.90 1 3 1 69.3 122.9 
Data obtained from a Pubchem (https://pubchem.ncbi.nlm.nih.gov/), b Drugbank (http://www.drugbank.ca/), c Chemspider (ACD/Labs) 
(http://www.chemspider.com/). 
Where Mwt: Molecular Weight, HBA: Number of Hydrogen Acceptors, HBD: Number of Hydrogen Donors, RB: Rotatable Bonds, 
TPSA: Topological Polar Surface Area, VM: Molar Volume, Sw: Solubility in water. 
 
